$MLTX news

The latest MLTX stock news: headlines, filings, AI summaries and sentiment for $MLTX, updated around the clock.

• MoonLake Immunotherapeutics Reports Q3 GAAP EPS of -$0.93 Seeking Alpha · November 4, 2026, 12:24 UTC
• MoonLake Immunotherapeutics - 10-Q Filing SEC EDGAR · November 4, 2026, 12:10 UTC
• MoonLake Immunotherapeutics - 8-K Filing SEC EDGAR · November 4, 2026, 12:07 UTC
• MoonLake Immunotherapeutics Submits BLA for Sonelokimab to Treat Hidradenitis Suppurativa Seeking Alpha · September 30, 2026, 21:48 UTC
• MoonLake Immunotherapeutics - 8-K Filing SEC EDGAR · September 30, 2026, 20:15 UTC
• MoonLake Immunotherapeutics - 8-K Filing SEC EDGAR · July 15, 2026, 10:01 UTC
• MoonLake Immunotherapeutics Stock Drops Due to Secondary Share Offering Yahoo Finance · June 25, 2026, 00:09 UTC
• MoonLake Immunotherapeutics Stock Drops on Secondary Share Offering Motley Fool · June 24, 2026, 23:49 UTC
• Stocks to Watch After Hours: MLTX, BBY, DPZ Seeking Alpha · June 22, 2026, 20:36 UTC
• MoonLake Immunotherapeutics Announces $150 Million Public Offering Seeking Alpha · June 22, 2026, 20:11 UTC
• MoonLake Immunotherapeutics - 8-K Filing SEC EDGAR · June 22, 2026, 11:01 UTC
• MoonLake Immunotherapeutics Reports Positive One-Year Results in Phase 3 Trials for Sonelokimab Seeking Alpha · June 21, 2026, 21:55 UTC
• MoonLake Immunotherapeutics CFO Sells Shares Under Prearranged Plan Motley Fool · June 5, 2026, 01:59 UTC
• H.C. Wainwright Raises Price Target for MoonLake Immunotherapeutics (MLTX) Following FDA Progress Yahoo Finance · June 2, 2026, 13:55 UTC
• MoonLake Immunotherapeutics - 8-K Filing SEC EDGAR · June 1, 2026, 10:21 UTC
• MoonLake Immunotherapeutics - 10-Q Filing SEC EDGAR · May 11, 2026, 13:21 UTC
• MoonLake Immunotherapeutics CEO Sells $2.8 Million Worth of Shares Yahoo Finance · April 18, 2026, 14:37 UTC
• MoonLake Immunotherapeutics CEO Sells $2.8 Million Worth of Shares Motley Fool · April 18, 2026, 14:17 UTC